Self-affirmed General Recognition of Safety for Xtramune™

NutriLeads has received positive feedback from an independent panel of experts that assessed the safety of its unique carrot-derived fiber that is specifically enriched for the rhamnogalacturonan-I pectin fraction, branded Xtramune™. It is NutriLeads’ first health ingredient planned for commercialization. The expertpanel concluded that the dossier, which reviews and summarizes all the available scientific evidence […]

NutriLeads attracts Series B funding to launch its innovative immune-enhancing ingredient, Xtramune™, and to progress its portfolio of health ingredients

3 September, 2020 Dutch Health Ingredients company, NUTRILEADS BV, announces the closing of a Series B financing round of 6.5 m€, led by ICOS CAPITAL together with GOEIE-GRUTTEN and existing shareholders DSM VENTURING, OOST NL, SHIFT INVEST and THUJA. NutriLeads, established in 2012, develops innovative natural food ingredients with clinically proven health benefits for application […]